PulseSight Biosciences
PrivateLast Round
Series A
Feb 13, 2025
Total Funding Raised
$54.14M
Company Overview
PulseSight Therapeutics is a biotechnology company that develops non-viral gene therapies for retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
non-viral gene therapyelectro-transfectionage-related macular degenerationAMDgeographic atrophyGAocular gene therapyretinal diseasesgene therapy deliverylong-acting therapyciliary muscle deliverysustained protein expressionDNA plasmidsophthalmologydrug delivery platform
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PulseSight Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
PulseSight Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 13, 2025 | ||||
| Seed | Feb 28, 2024 | ||||
| Series B Extension | Aug 4, 2021 | ||||
| Series B | Jan 8, 2020 | ||||
| Series A | Sep 16, 2016 | ||||
VC Round | Apr 11, 2013 |
PulseSight Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Seed, Series B Extension |
| Inserm Transfert | Series A, Seed, Series B, VC Round |
| Pontifax Venture Capital | Series A, Series B |
| +ND Capital | Seed |
| Pureos Bioventures | Series A, Series B, Seed |
| Boehringer Ingelheim Venture Fund | Series A, VC Round, Series B |
| Karista | Series A, Seed, Series B, VC Round |
PulseSight Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PulseSight Biosciences's valuation, stock price, and market status.